AMTB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Amerant Bancorp Inc (AMTB) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The financial performance is weak, with significant revenue and net income drops in the latest quarter. Analysts have mixed views, but the stock is facing challenges such as increased non-performing loans and hedge fund selling. Additionally, technical indicators do not show a strong upward trend, and there are no strong proprietary trading signals to support a buy decision. The negative sentiment from news and lack of positive catalysts further reinforce the recommendation to avoid this stock at this time.
The MACD is negative and contracting, RSI is neutral at 44.548, and moving averages are converging, indicating no clear trend. The stock is trading near its pivot level of 21.71, with resistance at 22.57 and support at 20.851.
NULL identified. Analysts have raised price targets slightly, but this is overshadowed by broader negative sentiment.
Hedge funds are selling heavily, and Zacks has added the stock to its Strong Sell list due to downward earnings revisions. Increased non-performing loans and insider neutrality further add to concerns.
In Q4 2025, revenue dropped to $19.57M (-74.13% YoY), net income dropped to $2.7M (-84.00% YoY), while EPS increased to 1.26 (+215.00% YoY). Gross margin remained at 0.
Analysts have mixed ratings. Piper Sandler raised the price target to $25 with an Overweight rating but noted challenges from non-performing loans. Keefe Bruyette and Raymond James raised price targets to $23 but maintain Market Perform and Outperform ratings, respectively. Analysts acknowledge a bumpy path and challenges in the bank's transition efforts.
